Premium
Treatment with obinutuzumab leads to worse outcomes in haematological patients diagnosed with Omicron variant COVID ‐19
Author(s) -
Shafat Tali,
Grupel Daniel,
Porges Tzvika,
Levi Itai,
Yagel Yael,
Nesher Lior
Publication year - 2022
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.18315
Subject(s) - covid-19 , obinutuzumab , medicine , immunology , virology , disease , lymphoma , rituximab , infectious disease (medical specialty) , outbreak
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom